Octagon Capital Advisors »

Erasca shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Erasca shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $23M 1.3M 18.32

More positions owned by Octagon Capital Advisors

Dianthus Therapeutics (DNTH)
Definium Therapeutics Com Shs (DFTX)
Abivax Sa Sponsored Ads (ABVX)
Cogent Biosciences (COGT)
Alumis (ALMS)
Arrivent Biopharma (AVBP)
Taysha Gene Therapies Com Shs (TSHA)
Bioage Labs (BIOA)
Mirum Pharmaceuticals (MIRM)
Kymera Therapeutics (KYMR)
Aktis Oncology (AKTS)
Xenon Pharmaceuticals (XENE)
Erasca Call Call Option
Palisade Bio (PALI)
Ocular Therapeutix (OCUL)

View all positions for Octagon Capital Advisors

Top funds holding Erasca

Octagon Capital Advisors
Group One Trading
Simplex Trading
Blue Owl Capital Holdings
Hrt Financial

View all funds holding Erasca